Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
CJC-1295 with DAC is a growth hormone-releasing hormone analogue incorporating a drug affinity complex intended to extend exposure through albumin binding. Human studies reported prolonged increases in growth hormone and IGF-1. Research centers on endocrine signaling and exposure duration; hormone changes alone do not establish muscle, recovery, or anti-aging outcomes.
Key research interests
• Growth hormone and IGF-1 signaling
• Albumin binding and prolonged exposure
• Endocrine response patterns
Not for human or veterinary use
CJC-1295 with DAC is a growth hormone-releasing hormone analogue incorporating a drug affinity complex intended to extend exposure through albumin binding. Human studies reported prolonged increases in growth hormone and IGF-1. Research centers on endocrine signaling and exposure duration; hormone changes alone do not establish muscle, recovery, or anti-aging outcomes.
Key research interests
• Growth hormone and IGF-1 signaling
• Albumin binding and prolonged exposure
• Endocrine response patterns
Not for human or veterinary use